A specialty pharmaceutical Company, which is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
The basis for owning this (I have real money at a loss right now) is that the industry is in for long, appreciating demand with the population aging and the economy prepared for inflation. Recession money is decently sheltered in basic necessities, such as groceries, utilities, and pharmaceuticals. Demand is only going to grow and this price opportunity presents a buying opportunity, even if the wait for a significant rise is 6mos to a year away. Another example of the market overreacting to a downward adjustment of earnings in the near term.